The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients
Crossref DOI link: https://doi.org/10.1007/s12253-016-0063-8
Published Online: 2016-04-22
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sárosi, Veronika
Balikó, Zoltán
Smuk, Gábor
László, Terézia
Szabó, Mariann
Ruzsics, István
Mezősi, Emese
Text and Data Mining valid from 2016-04-22